Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Opus Genetics, Inc.
| Metric | Opus Genetics, Inc. IRDHealthcare |
|---|---|
| Quality Score | 57 / 100 |
| Revenue (latest) | $14M |
| Net income (latest) | −$50M |
| Operating margin | −271.9% |
| Net margin | −349.3% |
| Return on equity | −323.1% |
| Return on assets | −98.7% |
| Return on capital (ROCE) | −90.9% |
| Debt / equity | 2.27× |
| Revenue growth (YoY) | 29.1% |
| Altman Z″ (distress) | -11.42 |
| Accruals / assets | −28.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.